B2B-RARE is a translational research project dedicated to improving the diagnosis and treatment of rare neuromuscular diseases. By integrating cutting-edge cell models, multi-OMICS technologies, and bioinformatics, we aim to better understand disease mechanisms and develop targeted therapeutic strategies.
We invite scientists, clinicians, and industry partners to connect with us and explore collaboration opportunities.
This project is funded by the European Union and the State of North Rhine-Westphalia as part of the EFRE/JTF Program NRW 2021-2027.
Company Details
- Employees
- 2
- Address
- Moorenstraße 5, Düsseldorf,north Rhine-Westphalia 40225,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://b2b-rare.de
- HQ
- Düsseldorf, North Rhine-Westphalia
- Competitors
- Logopädie Mülheim, ZaKI.D - Zentrum für angewandte Künstliche Intelligenz Duisburg, look2x, Denki Health, DGKJ - Deutsche Gesellschaft für Kinder- und Jugendmedizin, Irish Mass Spectrometry Society, ClearSurgery, Flow Factor, BG Universitätsklinikum Bergmannsheil, Institute of Tissue Medicine and Pathology at the University of Bern.
B2b-Rare Questions
B2B-Rare's website is https://b2b-rare.de
B2B-Rare's LinkedIn profile is https://de.linkedin.com/company/b2b-rare
B2B-Rare has
2 employees.
View email and phone details for 2
employees at B2B-Rare.
B2B-Rare's industry is
Biotechnology Research
B2B-Rare's top competitors are
Logopädie Mülheim,
Zaki.d - Zentrum Für Angewandte Künstliche Intelligenz Duisburg,
Look2x,
Denki Health,
Dgkj - Deutsche Gesellschaft Für Kinder- Und Jugendmedizin,
Irish Mass Spectrometry Society,
Clearsurgery,
Flow Factor,
Bg Universitätsklinikum Bergmannsheil,
Institute Of Tissue Medicine And Pathology At The University Of Bern.
B2B-Rare's categories are Biotechnology Research
